Irritable Bowel Syndrome: IBS Symptom and Symptom Journal
A number of expert investigators during a meeting in Rome, Italy, developed
a consensus definition and criteria for IBS, known as the “Rome” criteria.
At least 3 months of continuous or recurrent symptoms of:
1. Abdominal pain or discomfort that is:
a. Relieved with defecation and/or
b. Associated with a change in frequency of stool; and/or
c. Associated with a change in consistency of stool; and
2. Two or more of the following, at least on one-fourth of occasions
or days:
a. Altered stool frequency
b. Altered stool form (e.g. watery/loose stools or hard stools)
c. Altered stool passage (e.g. sensations of incomplete
evacuation after bowel movements, straining, or urgency)
d. Passage of mucus and/or
e. Bloating or feeling of abdominal distention
In addition, a number of other non-colonic symptoms may be present in
patients with IBS. These include: nausea, feeling full after eating only a
small meal, sensation of urinary urgency, incomplete emptying after
urinating, fatigue, and pain during intercourse.
IBS Symptom Journal
An IBS symptom journal can help you and your doctor figure out what triggers your IBS, and how to deal with those triggers.
Fill this out as soon as you experience symptoms. Print extra copies to have on hand.
Remember, a variety of factors can set off IBS: Certain types of food, the volume of food, stress, medicines, your menstrual cycle, and your environment.
You may find, for instance, that you tend to feel bloated after eating snacks during office meetings. Knowing what influences your eating and what causes you stress can help in developing prevention strategies.
Symptom Journal
# Date/Time Symptoms Began and Ended
Description of Symptoms (pain, bloating, diarrhea, constipation, etc.)
# Where Symptoms Began
# Pre-Symptom Activity
# Type of Food Eaten
# Amount of Food Eaten (Rate 1-10 with 10 as an excessive portion.)
# Medications Taken
# Suspected Trigger(s)
Hello my friends
Comment by Enzypeeagepay — May 14, 2008 @ 11:49 pm
Isotretinoin, when administered orally, is best absorbed when taken after a high fat meal, as it has a high level of lipophilicity. In a crossover study, it was found that the peak plasma concentration more than doubled when taken after a high fat meal versus a fasted condition. Isotretinoin is primarily (99.9%) bound to plasma proteins, mostly albumin. At least three metabolites have been detected in human plasma after oral administration of isotretinoin. These are 4-oxo-isotretinoin, retinoic acid and 4-oxo-retinoic acid. Isotretinoin also oxidises, irreversibly, to 4-oxo-isotretinoin. The metabolites of isotretinoin are excreted through both urine and feces. The mean elimination half-life is 21 hours, with a standard deviation from this mean of 8.2 hours.
buy accutane
Skin and Appendages: acne fulminans, alopecia (which in some cases persists), bruising, cheilitis (dry lips), dry mouth, dry nose, dry skin, epistaxis, eruptive xanthomas,7 flushing, fragility of skin, hair abnormalities, hirsutism, hyperpigmentation and hypopigmentation, infections (including disseminated herpes simplex), nail dystrophy, paronychia, peeling of palms and soles, photoallergic/photosensitizing reactions, pruritus, pyogenic granuloma, rash (including facial erythema, seborrhea, and eczema), sunburn susceptibility increased, sweating, urticaria, vasculitis (including Wegener’s granulomatosis; see PRECAUTIONS: Hypersensitivity), abnormal wound healing (delayed healing or exuberant granulation tissue with crusting; see PRECAUTIONS: PATIENT INFORMATION)
order accutane
From the time of its introduction the drug was known to have teratogenic potential, and pregnancies with the drug were strongly discouraged. When they occurred, they were found to have approximately 30% rates of congenital malformation, versus a 3-5% baseline risk.] Beginning in 1998, prescriptions of the drug came under scrutiny, as fewer than half of prescribers were testing for pregnancy, usually relying on less sensitive urine tests.] On the grounds that pregnancies by women taking the drug had been underreported by the manufacturer between 1982 and 2000, and that once generic manufacturers entered the market risk management was no longer centralized, the FDA instituted restrictions on prescribing and dispensing the drug, first with the “System to Manage Accutane Related Teratogenicity” (SMART) in 2000, and subsequently the iPLEDGE program in 2006. A retrospective cohort study recently found that pregnancy rates were quite high during the period (1 per 30 women per year), but 84% of pregnancies were ended by induced abortion.]
Comment by PripseOrece — May 27, 2008 @ 5:11 am